Evidence map›Paper›PMID 21278744›Full record

ArticleNature methods2011

Quantification of PtdInsP3 molecular species in cells and tissues by mass spectrometry.

Jonathan Clark, Karen E Anderson, Veronique Juvin, Trevor S Smith, Fredrik Karpe, Michael J O Wakelam, Len R Stephens, Phillip T Hawkins

Abstract read
In one paragraph

Article in Nature methods, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 162 papers.

0numbers the graph read from it
0cells of the map it votes in
162citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

162 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Oncometabolite 5-IPNature chemical biology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Emerging oralFrontiers in oral health · 2025
    Article
  19. Article
  20. Membrane-boundeLife · 2024
    Article

102 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Jonathan ClarkInositide Laboratory, Babraham Institute, Babraham Research Campus, Cambridge, UK.
Karen E Anderson
Veronique Juvin
Trevor S Smith
Fredrik Karpe
Michael J O Wakelam
Len R Stephens
Phillip T Hawkins

Funding

Biotechnology and Biological Sciences Research Council BB/H024824/1Biotechnology and Biological Sciences Research Council BBS/E/B/0000C218Biotechnology and Biological Sciences Research Council BBS/E/B/0000H213
6 · The paper itself

Abstract

Class I phosphoinositide-3-kinase (PI3K) isoforms generate the intracellular signaling lipid, phosphatidylinositol(3,4,5)trisphosphate (PtdIns(3,4,5)P(3)). PtdIns(3,4,5)P(3) regulates major aspects of cellular behavior, and the use of both genetic and pharmacological intervention has revealed important isoform-specific roles for PI3Ks in health and disease. Despite this interest, current methods for measuring PtdIns(3,4,5)P(3) have major limitations, including insensitivity, reliance on radiolabeling, low throughput and an inability to resolve different fatty-acyl species. We introduce a methodology based on phosphate methylation coupled to high-performance liquid chromatography-mass spectrometry (HPLC-MS) to solve many of these problems and describe an integrated approach to quantify PtdIns(3,4,5)P(3) and related phosphoinositides (regio-isomers of PtdInsP and PtdInsP(2) are not resolved). This methodology can be used to quantify multiple fatty-acyl species of PtdIns(3,4,5)P(3) in unstimulated mouse and human cells (≥10(5)) or tissues (≥0.1 mg) and their increase upon appropriate stimulation.

Indexed as

AnimalsCell Line, TumorCellsChromatography, LiquidFatsHumansLiverMass SpectrometryMiceNeutrophilsPhosphatidylinositol PhosphatesFatsphosphatidylinositol 3,4,5-triphosphatePhosphatidylinositol Phosphates

Identifiers

PMID21278744
PMCPMC3460242

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.